107 related articles for article (PubMed ID: 16110108)
1. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.
Beadsmoore CJ; Cheow HK; Sala E; Lomas DJ; Gibbs P; Save V; Alison ME; Balan KK
Br J Radiol; 2005 Sep; 78(933):841-4. PubMed ID: 16110108
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
Sun L; Wu H; Pan WM; Guan YS
World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
[TBL] [Abstract][Full Text] [Related]
3. Sonographic diagnosis of tumor thrombus formation in the umbilical vein: a case report.
Feng P; Feifei Z; Ning H; Yuxiang L
J Clin Ultrasound; 2011 May; 39(4):225-7. PubMed ID: 21283995
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K
J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443
[No Abstract] [Full Text] [Related]
5. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
Agarwal KK; Shah D; Shah N; Mayank M
Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
7. FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
Kurtovic J; Van Der Wall H; Riordan SM
Clin Nucl Med; 2005 Jun; 30(6):408-10. PubMed ID: 15891293
[No Abstract] [Full Text] [Related]
8. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
9. Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
Freesmeyer M; Lopatta E; Schierz JH; Steenbeck J; Opfermann T; Settmacher U
Nuklearmedizin; 2012; 51(1):N10-1. PubMed ID: 22336884
[No Abstract] [Full Text] [Related]
10. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
11. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
[TBL] [Abstract][Full Text] [Related]
13. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
Strobel K; Steinert HC; Bhure U; Koma AY; Gassmann N; Stöckli SJ
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):813. PubMed ID: 17225114
[No Abstract] [Full Text] [Related]
14. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
15. Important factors determining prognosis based on SUVmax in PET imaging.
Şahin E; Akcan AB
Turk J Gastroenterol; 2015 Sep; 26(5):442. PubMed ID: 26215070
[No Abstract] [Full Text] [Related]
16. Fluoromethylcholine PET in recurrent multifocal hepatoma.
Lenzo NP; Anderson J; Campbell A; Morandeau L; De Grado TR
Australas Radiol; 2007 Dec; 51 Suppl():B299-302. PubMed ID: 17991090
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
19. Application of positron emission tomography molecular probes in hepatocellular carcinoma biological imaging.
He TT; Tian JH
Chin Med Sci J; 2011 Jun; 26(2):113-8. PubMed ID: 21703120
[TBL] [Abstract][Full Text] [Related]
20. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
